Keywords
Post-partum, contraception, birth spacing, family planning, intrauterine device, Rwanda
Post-partum, contraception, birth spacing, family planning, intrauterine device, Rwanda
The World Health Organization (WHO) recommends post-partum family planning as safe, effective, and cost-effective for prevention of unintended pregnancy, prevention of abortion, birth spacing, and improvement of maternal and newborn health1,2. Like many sub-Saharan African countries, Rwanda is committed to reducing unmet family planning need, particularly in postpartum women3,4.
The 2015 Rwandan Demographic and Health Survey (DHS) estimated that 19% of women have an unmet need for family planning5 and the 2010 Rwandan DHS estimated that 51% of women had an unmet need for postpartum (within two years of delivery) family planning6. In particular, the copper intrauterine device (IUD) is highly-effective, cost-effective, and can be used immediately post-partum or after 4 weeks post-partum regardless of breastfeeding7,8. However, the post-partum IUD (PPIUD) remains extremely underutilized across sub-Saharan Africa, including in Rwanda8.
In much of the developing world, women with limited access to medical care are often able to attend antenatal care (ANC), labor and delivery (L&D), and infant vaccination services making these visits unique opportunities to address post-partum family planning needs9,10. The Rwandan Ministry of Health (MOH) previously supported efforts to implement PPIUD services in four district hospitals and eight health centers and found that clinic staff successfully incorporated new skills into ANC and maternity services, inserting 478 PPIUDs over 15 months11. As a result, the Rwandan MOH developed training curricula and reporting mechanisms, and PPIUD is part of the Government’s Family Planning 2020 Commitment12.
However, despite capacity building and interest, uptake of PPIUD services in Rwanda remains extremely low, and overall, the IUD only comprises 2.5% of the method mix among contracepting women between the ages of 15–49 in the 2015 Rwandan DHS (see Family Planning 2020 site).
This low IUD uptake is hypothesized to be due to lack of clinic ‘champion’ stakeholders promoting the service, low provider motivation and comfort with the IUD, lack of optimized operational procedures, the often overlooked role of male involvement, and lack of demand-creation strategies informed by clients’ needs and preferences11,13–16. Research particularly highlights the need to create demand through providing comprehensive information on contraceptive methods to increase knowledge about benefits and side effects, address misconceptions, and discuss family planning desires with women and couples17–19. Educational and demand creation efforts are particularly important for the IUD which is less well-known versus other modern methods in sub-Saharan Africa20–23.
Our objective was to develop and pilot test an evidence-based, multi-level intervention targeting both supply, demand, and sustainability to increase uptake of the PPIUD (defined here as uptake up to six weeks after delivery) in Kigali, the capital of Rwanda. Our primary aims were to increase the number of: workers trained to promote the PPIUD to couples/clients in health facilities and the community, providers trained and certified to insert and remove PPIUDs, couples/clients receiving PPIUD educational promotions, and women receiving a PPIUD up to six weeks after delivery. This study was conducted by researchers at Projet San Francisco (PSF).
The Emory University Institutional Review Board (IRB) and the Rwanda National Ethic Committee (RNEC) approved the research component (focus group discussions and surveys) of the project (IRB 00001497). Written informed consent was obtained from all participants prior to enrollment. The Emory University IRB determined the programmatic service delivery component of the project (PPIUD promotions and insertions provided by government clinic staff) was exempt from review.
To develop an evidence-based, multi-level intervention to improve PPIUD supply and demand coordination, our innovative strategy combined behavioral science and operations research methods, specifically using a multi-level implementation science framework based on Greenhalgh et al.24 and the Theory of Planned Behavior25. Drawing on input from stakeholders, providers, community health workers, and couple/clients, we designed the intervention to address barriers at multiple-levels. This framework is outlined in Figure 1 and indicates intervention activities designed to change an agent’s attitudes, norms, and perceived control, which in turn affect their intention to either support, provide, promote, or take up a PPIUD. These activities are described in detail below.
Grey boxes indicate intervention activities designed to change attitudes, norms, and perceived control. PPIUD: post-partum intrauterine device; PPFP: post-partum family planning; FPTWG: Family Planning Technical Working Group; ANC: antenatal care; L&D: labor and delivery; FP: family planning; CHW: community health worker; PBF: performance-based financing; MOH: Ministry of Health.
Throughout the intervention we received logistical and technical support from a collaborative group of stakeholders at community, facility, non-governmental, and governmental levels. This included the Rwanda MOH, the District Mayors, the Rwandan Family Planning Technical Working Group, and clinic directors and nurse-administrators at the selected hospitals and health centers.
In May-June 2017, a PSF nurse counselor (RS) and a study physician (RI) reviewed government monthly reports from Kigali health facilities to select the highest L&D-volume hospitals and health centers. Two hospitals (and their two associated health centers) and two additional health centers were selected. A PSF nurse counselor (RS) and a study physician (RI) then assessed infrastructure, staff trained in long-acting reversible contraception (IUD or implant) insertions, staff in L&D and family planning, and staff interested as potential trainees for PPIUD services in the selected health facility. They reviewed IUD stocks and any procedures supporting PPIUD supply or demand.
Through formative work in May-July 2017, PSF staff evaluated knowledge, attitudes, and practices regarding PPIUD services among community health workers (CHW) and providers at two high volume health centers which were not selected for our intervention (unpublished manuscript under review; Da Costa V, Ingabire R, Sinabamenye R, Karita E, Umutoni V, Hoagland A, Allen S, Mork E, Parker R, Mukamuyango J, Haddad L, Nyombayire J, Wall KM. An exploratory analysis of factors associated with interest in postpartum intrauterine device (IUD) uptake among pregnant women and couples in Kigali, Rwanda. Submitted 2018; unpublished manuscript under review; Da Costa V, Ingabire R, Sinabamenye R, Karita E, Umutoni V, Hoagland A, Allen S, Mork E, Parker R, Mukamuyango J, Haddad L, Nyombayire J, Wall KM. Perceptions of the postpartum intrauterine device (PPIUD) and implant among pregnant women and couples in Kigali, Rwanda. Submitted 2018). As Rwanda uses a performance-based financing (PBF) system, we also explored provider knowledge of the current PBF structure and other insurance programs for family planning method provision, and asked whether these influenced the methods they provide. We also evaluated knowledge, attitudes, and practices among pregnant women and couples during early ANC visits (men often attend these visits with their partners). Survey and focus group topics included: demographics; previous pregnancy, birth spacing, and family planning history; postpartum long-acting reversible contraception knowledge, attitudes, and practices; and personal and community perceptions of long-acting reversible contraception. Each survey and focus group discussion took approximately 45 minutes to complete, and each individual study participant was compensated $3.60 United States Dollars (USD). Information gathered from this formative work led to the development of the PPIUD educational and promotional flipchart (Supplementary File 1).
In August 2017, health care providers (nurses and midwives working in L&D and family planning) from our selected government health facilities were trained by two national PPIUD trainers located at the selected district hospitals. The training included a 2-day didactic session conducted at PSF (adapted from didactic and practical training materials developed by JHPIEGO and USAID in collaboration with the MOH).
We trained a maximum of 12 trainees per didactic session. The didactic training included information about IUD and PPIUD insertion and removal procedures and follow-up, the use of the PPIUD flipchart in counseling, mock counseling sessions, as well as PPIUD insertion and removal trainings using ‘Mama-U’ (Laerdal Medical) postpartum uterus models. Pre- and post-training tests (adapted from the USAID and Maternal and Child Health Integrated Program Postpartum IUD Training Guide26; Supplementary File 2) consisted of 10 true or false questions and were administered before and after the training.
After passing the didactic training session, two trainees at a time would conduct PPIUD insertions at a selected district hospital under the supervision of a national trainer. The trainees were required to insert correctly and comfortably five PPIUDs under supervision to be PPIUD certified. These five insertions had to include at least one of the following PPIUD insertion timings: immediate post-placental, 10 minutes to 48 hours post-delivery, and 4-6-weeks post-delivery. Checklists for PPIUD insertion practices guided the certification process. Intra-cesarean and post-abortion IUD insertions were provided by previously trained doctors and those certified in PPIUD.
In addition to training PPIUD providers to use the PPIUD promotional flipchart, we trained government clinic staff in family planning, ANC, L&D, and infant vaccination to promote the service at the selected facilities. Trainings were comprised of a 3-hour long didactic session led by PSF staff followed by one supervised promotion session. Additionally, we trained CHWs affiliated with the selected health facilities to use the flipchart to promote post-partum family planning in the community beginning in March 2018. CHWs received a 1-day training on the use of the PPIUD flipchart and couples’ family planning counseling strategies. Women were referred to the facility by their CHW if interested to receive an IUD. Thus, women and couples were provided with PPIUD information at many different time points at the selected health facilities (during ANC, L&D, and infant vaccination up to 6 weeks post-delivery) as well as in the community.
PPIUD follow-up appointments were scheduled 10 days after IUD insertion. Those who had insertions within 48 hours of delivery and who missed their 10-day follow-up visit were assessed at their infant’s first vaccination visit 6 weeks post-partum. Women coming for follow-up appointments were asked if they had complaints, and a pelvic exam for infection and IUD placement was performed. IUD strings were trimmed as needed and a pelvic ultrasound was recommended if the strings were not visible during physical exam. Women whose IUDs expulsed or who requested a removal were offered the family planning method of their choice. To increase follow-up, in March 2018 we began providing CHWs with lists of clients in their catchment areas who were pending follow-up to remind those women about their appointments.
PPIUD trainees were provided with per diem and transport reimbursement for the time spent training ($5.79 USD per day for approximately two weeks of training). All other reimbursements began in March 2018. Reimbursements to the selected facilities for administrative costs associated with implementing the PPIUD program were provided at $57 USD per month. Using the PBF system as a guide27, CHWs were incentivized $0.57 USD per client presenting their referral when requesting a PPIUD and providers were reimbursed $1.20 USD/PPIUD insertion. These payments were made to their facility and included with their regular PBF pay. We began providing transportation reimbursement for women to attend PPIUD follow-up visits ($2.29 USD/client) as follow-up visits were not part of the routine schedule for new mothers.
PPIUD service delivery and promotions began in August 2017. A unique code unlinked to patient identifiers allowed tracking of clients from the community and ANC through L&D and infant vaccination. Since promotions occurred in several settings, promotions given by CHW were tracked using referral slips. Promotions in ANC included a group talk followed by one-on-one counseling for those expressing interest in post-partum family planning. Those receiving one-on-one counseling had their method of interest and estimated date of delivery recorded. During insertion, provider perception of ease of insertion, client anxiety during insertion, and client pain during insertion were captured on scales of 1–10. During follow-up, data collected included method expulsion, genital infection, or method failure (i.e., incident pregnancies occurring after insertion), and client satisfaction with the method was captured on a scale of 1–10. Data was recorded in government log books, extracted and cleaned for data entry into tablets weekly by the PSF field team through the mobile data collection platform Survey CTO v2.41 (Dobility, Cambridge, USA), and finally uploaded into a Microsoft Access database.
Analyses were performed using SAS version 9.4 (Cary, NC). We tabulated, by facility: number of providers trained and certified; number of promoters trained; number of clients who received a one-on-one promotion from a CHW or in a health facility; total number of PPIUDs inserted (overall and by timing of insertion); and number of follow-up visits. From these data, we calculated the proportion of PPIUD uptake among women who delivered at one of our selected facilities and the proportion of insertions by insertion timing (Table 1). We also plotted PPIUD uptake over time by facility (Figure 2) and by timing of insertion (Figure 3), both after implementation of the intervention and in the six months prior. We then used descriptive statistics to describe insertion and follow-up data (Table 2).
Muhima Hospital and Health Center | Kacyiru Hospital and Health Center | Remera Health Center | Kinyinya Health Center | Total | ||||||
---|---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | N | % | |
Pregnant women promoted to | 3790 | 2656 | 2025 | 2089 | 10560 | |||||
Women promoted to who delivered in a study L&D ward* | 3277 | 86% | 2564 | 97% | 1540 | 76% | 1692 | 81% | 9073 | 86% |
Promotions delivered during: | ||||||||||
Antenatal care | 401 | 12% | 20 | 1% | 585 | 38% | 780 | 46% | 1786 | 20% |
L&D | 2769 | 84% | 2544 | 99% | 332 | 22% | 216 | 13% | 5861 | 65% |
Post-partum | 1 | 0% | 0 | 0% | 254 | 16% | 296 | 17% | 551 | 6% |
Infant vaccination visit | 106 | 3% | 0 | 0% | 369 | 24% | 400 | 24% | 875 | 10% |
Total number of PPIUD inserted | 1061 | 32% | 994 | 39% | 310 | 20% | 268 | 16% | 2633 | 29% |
Post-placental | 513 | 48% | 744 | 75% | 197 | 64% | 136 | 51% | 1590 | 60% |
Intra-cesarean | 189 | 18% | 148 | 15% | 0 | 0% | 0 | 0% | 337 | 13% |
10 minutes to 48 hours | 268 | 25% | 55 | 6% | 79 | 25% | 47 | 18% | 449 | 17% |
4 to 6 weeks | 58 | 5% | 22 | 2% | 34 | 11% | 85 | 32% | 199 | 8% |
Post-abortion | 33 | 3% | 25 | 3% | 0 | 0% | 0 | 0% | 58 | 2% |
Percent increase in monthly insertions comparing February 2017-July 2017 to August 2017-July 2018: 2,749%. PPIUD: post-partum intrauterine device; CHW: community health worker; PBF: performance-based financing; ANC: antenatal care; L&D: labor and delivery; IV: infant vaccination.
PPIUD: post-partum intrauterine device; CHW: community health worker; PBF: performance-based financing; ANC: antenatal care; L&D: labor and delivery; IV: infant vaccination.
Muhima Hospital and Health Center | Kacyiru Hospital and Health Center | Remera Health Center | Kinyinya Health Center | Total | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Mean/N | SD/% | Mean/N | SD/% | Mean/N | SD/% | Mean/N | SD/% | Mean/N | SD/% | |
Among women receiving a PPIUD insertion (N = 2,633) | ||||||||||
Age (mean, SD) | 28.3 | 6.4 | 28.8 | 5.6 | 28.1 | 5.5 | 27.8 | 6.2 | 28.4 | 6.0 |
Parity (mean, SD) | 2.4 | 1.4 | 2.4 | 1.5 | 2.6 | 1.4 | 2.5 | 1.4 | 2.4 | 1.4 |
Provider perception: ease of insertion (mean, SD)* | 9.4 | 0.7 | 8.5 | 1.1 | 9.7 | 1.0 | 9.7 | 0.6 | 9.2 | 1.0 |
Patient perception: anxiety during insertion (mean, SD)* | 1.1 | 0.4 | 2.2 | 0.7 | 3.9 | 2.1 | 1.1 | 0.6 | 1.8 | 1.3 |
Patient perception: pain during insertion (mean, SD)* | 1.1 | 0.4 | 2.5 | 0.9 | 3.6 | 2.0 | 1.0 | 0.2 | 1.9 | 1.3 |
Among attending PPIUD follow-up (N = 1,418) | ||||||||||
Expulsion (N, %) | ||||||||||
Yes | 37 | 7% | 29 | 5% | 6 | 3% | 8 | 5% | 80 | 6% |
IUD reinserted | 27 | 73% | 10 | 34% | 3 | 50% | 7 | 88% | 47 | 59% |
Implant inserted | 2 | 5% | 5 | 17% | 1 | 17% | 1 | 13% | 9 | 11% |
No LARC inserted | 8 | 22% | 14 | 48% | 2 | 33% | 0 | 0% | 24 | 30% |
No | 465 | 93% | 514 | 95% | 191 | 97% | 168 | 95% | 1338 | 94% |
Infection (N, %) | ||||||||||
Yes | 5 | 1% | 1 | 0% | 0 | 0% | 0 | 0% | 6 | 0.4% |
No | 497 | 99% | 540 | 100% | 197 | 100% | 176 | 100% | 1410 | 100% |
Failure (N, %) | ||||||||||
Yes | 0 | 0% | 0 | 0% | 0 | 0% | 0 | 0% | 0 | 0% |
No | 502 | 100% | 543 | 100% | 197 | 100% | 176 | 100% | 1418 | 100% |
Removal (N, %) | ||||||||||
Yes | 7 | 1% | 6 | 1% | 4 | 2% | 3 | 2% | 20 | 1% |
No | 494 | 99% | 536 | 99% | 193 | 98% | 173 | 98% | 1396 | 99% |
Patient report of satisfaction with PPIUD (mean, SD)* | 9.9 | 0.6 | 9.9 | 0.5 | 10.0 | 0.2 | 9.9 | 0.4 | 9.9 | 0.5 |
The health facilities selected included Muhima and Kacyiru hospitals (and their associated health centers) and Remera and Kinyinya health centers. The two hospitals, Muhima and Kacyiru, provide routine L&D services for their adjoining health centers and also receive referrals of high-risk and complex obstetric cases from several other health centers. Muhima and Kacyiru health centers provide ANC, family planning, and infant vaccination. The other two health centers, Kinyinya and Remera, were distant from the selected hospitals and from each other, and included routine L&D as well as ANC, family planning, and infant vaccination services. Complex and high-risk obstetric cases from these latter two health centers were referred to nearby hospitals not included in this study. All facilities had infrastructure for IUD insertions and procurement but did not have PPIUD insertion kits or Kelley forceps which were procured.
Four client focus groups comprised of 32 participants and 14 provider interviews informed the development of surveys which were conducted among 14 health providers, 24 CHWs, and 150 women or couples attending ANC visits. Information gathered from this formative work led to the development of the PPIUD promotional flipchart.
The PPIUD flipchart contained information on the importance of birth spacing, a description of the IUD including efficacy and side effects, and also explained PPIUD insertion timing and expulsion rates. The flipchart included answers to the most frequent client misconceptions about the PPIUD including breastfeeding, heavy bleeding, and its effect on sexual intercourse. Though the focus of the promotional flipchart was on the PPIUD, the promotions included discussion of the other post-partum contraceptive options which are more well-known and widely available21. The flipchart was designed to be delivered by clinic providers during ANC, L&D, infant vaccination, or by CHWs in the community to both pregnant women and couples.
We trained a total of 83 staff to promote PPIUD to couples/clients in-clinic and in the community. 39 providers were trained to deliver the service and 90% of those were certified. Trainees were midwives and nurses working in L&D (85%) or from family planning clinics (15%). All trainees were women.
From August 2017-July 2018, n=9,073 pregnant women were promoted to who later delivered at one of the selected facilities (48% of these expressed interest in PPIUD at the time of promotion). Most promotions took place during L&D (65%) or ANC (20%). Most (95%) of the women only received one promotion, with 4% receiving two promotions (and 1% receiving three to four promotions). Overall, n=2,633 PPUIDs were inserted (29% PPIUD uptake) (Table 1). Timing of promotion was associated with uptake (p<0.05), with highest uptake for promotions delivered during L&D (35%) versus the lowest uptake for promotions delivered during ANC (9%, Dataset 128). Increasing number of promotions received was not statistically significantly associated with PPIUD uptake, but a trend was observed (p=0.07, Dataset 128).
In the 6-months prior to the intervention (February 2017-July 2017), 46 PPIUDs were inserted in the selected health facilities. The percent increase comparing monthly PPIUD insertions between February 2017-July 2017 to August 2017-July 2018 was 2,749% (Figure 2). We saw an immediate increase in PPIUD uptake as training/promotions began which decreased slightly after initial trainings/supervised certifications ended. Once PBF-incentives began along with training of CHWs to promote PPIUDs in the community, we again observed an increase in insertions. Insertions decreased in June 2018 as seven PPIUD certified nurses began their annual or maternity leave, followed by a subsequent increase as certified providers rearranged their workloads accordingly to compensate.
In the initial three months of the program, insertions placed between 10 minutes to 48 hours post-delivery were the most common, but from November 2017 onward post-placental insertions were the most common. Overall, 60% of insertions were immediately post-placental, 17% occurred 10 minutes to 48 hours post-delivery, 8% occurred 4 to 6 weeks post-delivery, 13% occurred intra-cesarean section, and 2% occurred post abortion (Figure 3).
Of the 2,633 women receiving PPIUDs, the average age was 28.4 and average parity was 2.4. Provider perception of ease of insertion was high across facilities (average score of 9.2/10), and patient perception of anxiety and pain were low (average scores of 1.8/10 and 1.9/10, respectively) (Table 2). Remera health center had slightly higher than average patient anxiety and pain scores relative to the other facilities.
N=1,418 (60%) women who were due for PPIUD follow-up visits attended them. Overall proportions of expulsions were low at 6% (N=80), and over half (59%) of women who experienced an expulsion had an IUD reinserted. Expulsion proportions were similar for post-placental, 10 minutes to 48 hours post-delivery, intra-caesarian, and 4 to 6 weeks post-delivery insertions, but the small number of post-abortion insertions had a higher expulsion proportion (3/18, 17%, Dataset 129). Infections were extremely uncommon across all facilities at 0.4%, and no cases of IUD failure were identified. One percent of women requested removals, with the most commonly cited reason for removal being that the husband (30%) or the woman (25%) did not like the method (Dataset 129). Overall satisfaction with the PPIUD was very high across all facilities (average score of 9.9/10).
In this PPIUD implementation in government health facilities, we focused on supply, demand, and stakeholder engagement to significantly increase the provision and uptake of the PPIUD. The proportion of women who were made aware of this service and selected this method after delivery was very high (29%) as was the proportion of insertions that were post-placental (60%). Client satisfaction with the service was high and removal, expulsion, and infection proportions were low.
This study demonstrated that it is feasible to train government providers to deliver consistent, quality PPIUD services that are adaptable with their current workload. Staff turnover and leave was a challenge, and new and refresher trainings will be needed over longer timeframes. However, staff began to train each other near the end of the implementation and took over intra-cesarean section insertions from previously trained doctors, indicating the sustainability of our model. PBF-type incentives appeared to support providers and facilities in providing the service (offsetting administrative costs incurred by facilities and time costs to providers). Though we encountered no issues with stockouts, other studies have observed such challenges, and the potential for device stockouts must be monitored.
Provider training and infrastructure alone is not sufficient to ensure the success of PPIUD services and increase demand, especially for the less well-known IUD21,30, and several demand creation strategies may be needed. We observed a significant increase in PPIUD uptake pre- versus post- intervention after PPIUD supply and demand coordination began. Demand was generated by both in-clinic promotions as well as by CHWs affiliated with facilities. In future studies, we will expand CHW promotions and conduct comparative effectiveness studies of these two promotional strategies. A study in Nigeria showed that repeated post-partum family planning promotions over multiple ANC sessions increased post-partum family planning use31, as we similarly observed a trend for the effect of multiple promotions.
Most PPIUD insertions were post-placental (60%) and the second most frequent timing of insertion was 10 minutes to 48 hours after delivery indicating that our promotions often lead to insertion before women leave the facility after delivery. In a study that integrated PPIUD services into maternal care facilities in six low- and middle-income countries, researchers found that in Rwanda, 27% of PPIUD insertions were post-placental, 43% were intra-cesarean, and 30% were within 10 minutes to 48 hours of delivery; in this study, insertion timings varied widely by country with Rwanda having the lowest proportion of insertions being post-placental10. In a study in providing post-partum family planning services in West and Central Africa, most PPIUD insertions were intra-cesarean (33%) with relatively fewer being post-placental (20%). The authors suggest this may be due to weak post-partum family planning counseling in ANC clinics32.
PPIUD follow-up proportions may be affected by women attending other nearby health centers not included in this study for follow-up, or simply not attending follow-up visits. Similarly, in a study in providing post-partum family planning services in West and Central Africa, 42% of women who had a PPIUD inserted also attended follow-up (13.8% in person at the clinic between 2–6 weeks, and 28.6% by phone at 6 weeks)32.
Of those with PPIUD follow-up appointments, reported satisfaction with the method was high, and we observed very few adverse outcomes during the study. PPIUD expulsions were relatively rare (6%) and were highest for post-abortion insertions. Infections and removals were also rare (<=1% of insertions) and no failures were observed. Similarly, in a study that integrated PPIUD services into maternal care facilities in low- and middle-income countries, expulsion rates were low (ranging from 2–4%), infection rates were low (0–1%), and removals ranged from 1%–11%10. In a study in providing post-partum family planning services in West and Central Africa, 0.8% of PPIUD users self-reported expulsions and only 0.5% (n=12) requested removal (10 desired pregnancy and two had husbands who disapproved of the PPIUD)32. These and our data are reassuring regarding PPIUD insertions and adverse events.
Given that the majority of the removals in our study were due to male partner’s not liking the method, male involvement during promotions may be important. A review of 26 post-partum family planning studies in low- and middle-income countries found that male partner involvement may increase knowledge and use of postpartum contraception33, and other studies found male partner involvement is important for postpartum contraception uptake and continued use28,34–36. We are currently conducting focus groups and surveys to further explore the role of male involvement in post-partum family planning choices.
PBF-type incentives appeared to increase the uptake of PPIUDs in our study. Under the current Rwandan PBF structure, providers receive a flat rate for all family planning methods provided to a new user. Thus, the IUD which takes considerably more time and skill to provide is reimbursed at the same rate as methods that are easier to administer such as OCPs and injectables. This could create a disincentive to providing IUDs. We are currently exploring stakeholder and policymaker perceptions related to restructuring the PBF reimbursements for family planning methods based on the skill and time it takes to provide them.
Several limitations warrant discussion. Group promotions were often conducted in ANC, L&D, and infant vaccination and time constraints limited the number of women who could receive a subsequent one-on-one counseling session to those who were interested in post-partum family planning. As a result, more women heard about the PPIUD than were recorded. The two hospitals had large volume L&D services that included referrals of high-risk and complex cases from non-participating clinics. If those PPIUD clients did not return to one of our selected health facilities for follow-up assessment, they would not be captured. Because we were collecting service delivery data, we do not have extensive demographic information to explore demographic factors associated with uptake. Similarly, we did not collect data on why women selected or did not select the PPIUD. We are currently conducting surveys with women who received our post-partum family planning promotions to explore these reasons. Finally, given the pre-post study design, it is not possible to rule out the effect of secular changes on PPIUD uptake, though no national interventions or other similar projects were taking place in the capital during our implementation.
With renewed interest in post-partum IUD services, this comprehensive multi-level intervention is extremely well-timed and has the potential to make a significant impact on PPIUD uptake in Rwanda. Lessons learned from this and other PPIUD interventions show the critical and interconnected role of advocacy, training, mentored supervision, demand creation, and monitoring and evaluation. We are working with stakeholders to share best practices, and a cost-effectiveness analysis of the intervention is underway. We are planning to expand the service to other hospitals and health centers in Kigali which could become training centers for other facilities. We believe that our PPIUD implementation model, which achieved high PPIUD acceptance with high satisfaction and low adverse effects, is replicable and expandable.
The Emory University Institutional Review Board (IRB) and the Rwanda National Ethic Committee (RNEC) approved the research component (focus group discussions and surveys) of the project (IRB 00001497). Written informed consent was obtained from all participants prior to enrollment. The Emory University IRB determined the programmatic service delivery component of the project (PPIUD promotions and insertions) was exempt from review.
Underlying data is available from Harvard Dataverse. Dataset 1: Replication Data for: an interim evaluation of a multi-level intervention to improve post-partum intrauterine device (PPIUD) services in Rwanda https://doi.org/10.7910/DVN/WLZ7PC29
Data is available under a Creative Commons Zero (“CC0”) Public Domain Dedication Waiver
This work was supported by the Bill & Melinda Gates Foundation [OPP1160661]. Additional support came from the Emory University Research Council Grant [URCGA16872456], Emory Global Field Experience Award, the Emory Center for AIDS Research [P30 AI050409], the National Institutes of Health [NIAID R01 AI51231; NIAID R01 AI64060; NIAID R37 AI51231], Emory AITRP Fogarty [5D43TW001042], and the International AIDS Vaccine Initiative (IAVI) [SOW2166]. The contents of this manuscript are the responsibility of the authors and do not necessarily reflect the views of the funders.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Supplementary File 1: Post-partum intrauterine device educational and promotional flipchart.
Click here to access the data.
Supplementary File 2: Pre- and post-training test.
Views | Downloads | |
---|---|---|
Gates Open Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Partly
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: I am an employee of Jhpiego, whose training materials were referenced. We have been involved in PPIUD trainings for several years in Rwanda, with other funding streams (USAID) and this may be one of the facilities where we’ve worked or provided technical support. Personally, I’ve not been involved in the PPIUD trainings, but our in country Jhpiego colleagues have been.
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
Competing Interests: No competing interests were disclosed.
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
Competing Interests: No competing interests were disclosed.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |||
---|---|---|---|
1 | 2 | 3 | |
Version 3 (revision) 04 Feb 19 |
read | ||
Version 2 (revision) 10 Oct 18 |
read | read | read |
Version 1 20 Aug 18 |
read | read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Register with Gates Open Research
Already registered? Sign in
If you are a previous or current Gates grant holder, sign up for information about developments, publishing and publications from Gates Open Research.
We'll keep you updated on any major new updates to Gates Open Research
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)